Bunge Global Tops 200-Day MA; BofA Raises Target to $112 and UBS to $108
Bunge Global shares surged above the 200-day moving average of $86.33, reaching $99.28 (last at $97.35) on volume of 2.36 million, prompting Bank of America to lift its price target to $112 and UBS to $108. VP Christos Dimopoulos sold 25,300 shares at $94.37, cutting his stake 19.5%.
1. Compelling Valuation Post-Merger
Following its July merger with Viterra, Bunge Global SA is trading at a 12.7x forward price-to-earnings multiple, representing a roughly 15% discount to competitor Archer-Daniels-Midland’s forward P/E. This valuation gap reflects market skepticism around integration execution, even as Bunge’s enlarged origination and processing footprint now handles more than 60 million metric tons of oilseeds and grains annually. At 12.7x forward earnings, investors gain exposure to one of the industry’s most diversified portfolios at a notable discount to peers commanding multiples in the mid-teens.
2. Integration Enhances Logistics Granularity and Margin Expansion
The combined company operates over 200 port terminals, 35 export facilities and a rail fleet exceeding 1,000 cars, delivering granular control over global logistics. Management estimates that optimization of Viterra’s Australian grain network alone will unlock $150 million in annual cost savings by 2026. Enhanced routing flexibility across North American Gulf Coast elevators and South American river terminals is projected to boost segment EBITDA margins by 120–150 basis points over the next two years.
3. Firm Guidance with Substantial Upside Potential
Bunge reiterated full-year adjusted EPS guidance of $7.30–$7.60 and forecasted free cash flow of more than $2.5 billion. Analysts model 2026 synergy realization at $350–$400 million, implying an EPS uplift of $0.80–$0.90. With consensus estimates at $8.20 for 2026, shares could see 20% appreciation if synergy targets are met and land markets remain supportive. Management has committed to deploying 60% of incremental free cash flow toward debt reduction and shareholder returns, further enhancing return on invested capital.